These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27992512)

  • 1. 68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.
    Kazmierczak PM; Todica A; Gildehaus FJ; Hirner-Eppeneder H; Brendel M; Eschbach RS; Hellmann M; Nikolaou K; Reiser MF; Wester HJ; Kropf S; Rominger A; Cyran CC
    PLoS One; 2016; 11(12):e0168248. PubMed ID: 27992512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. αvß3-Integrin-Targeted Magnetic Resonance Imaging for the Assessment of Early Antiangiogenic Therapy Effects in Orthotopic Breast Cancer Xenografts.
    Kazmierczak PM; Schneider M; Habereder T; Hirner-Eppeneder H; Eschbach RS; Moser M; Reiser MF; Lauber K; Nikolaou K; Cyran CC
    Invest Radiol; 2016 Nov; 51(11):746-755. PubMed ID: 27082316
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wang Y; Liu H; Yao D; Li J; Yang S; Zhang C; Chen W; Wang D
    J Nanobiotechnology; 2019 Oct; 17(1):105. PubMed ID: 31604441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an Integrin α
    Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
    Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Characterization of 4
    Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
    J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhang J; Mao F; Niu G; Peng L; Lang L; Li F; Ying H; Wu H; Pan B; Zhu Z; Chen X
    Theranostics; 2018; 8(4):1121-1130. PubMed ID: 29464003
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrin α(v)β₃-targeted radiotracer (99m)Tc-3P-RGD₂ useful for noninvasive monitoring of breast tumor response to antiangiogenic linifanib therapy but not anti-integrin α(v)β₃ RGD₂ therapy.
    Ji S; Zheng Y; Shao G; Zhou Y; Liu S
    Theranostics; 2013; 3(11):816-30. PubMed ID: 24312152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does imaging αvβ3 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?
    Rylova SN; Barnucz E; Fani M; Braun F; Werner M; Lassmann S; Maecke HR; Weber WA
    J Nucl Med; 2014 Nov; 55(11):1878-84. PubMed ID: 25278514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma.
    Kazmierczak PM; Burton NC; Keinrath G; Hirner-Eppeneder H; Schneider MJ; Eschbach RS; Heimer M; Solyanik O; Todica A; Reiser MF; Ricke J; Cyran CC
    PLoS One; 2018; 13(10):e0204930. PubMed ID: 30281669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
    Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
    Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Provost C; Rozenblum-Beddok L; Nataf V; Merabtene F; Prignon A; Talbot JN
    Mol Imaging Biol; 2019 Apr; 21(2):297-305. PubMed ID: 29948641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of early response to the tyrosine kinase inhibitor ZD4190.
    Yang M; Gao H; Yan Y; Sun X; Chen K; Quan Q; Lang L; Kiesewetter D; Niu G; Chen X
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1237-47. PubMed ID: 21360246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging of αvß3 expression in cancer patients.
    Gaertner FC; Schwaiger M; Beer AJ
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):309-26. PubMed ID: 20639816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.
    Cui Y; Liu H; Liang S; Zhang C; Cheng W; Hai W; Yin B; Wang D
    Oncotarget; 2016 May; 7(19):27243-54. PubMed ID: 27029065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
    Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X
    J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging. Preclinical investigation and dosimetry.
    Buchegger F; Viertl D; Baechler S; Dunet V; Kosinski M; Poitry-Yamate C; Rüegg C; Prior JO
    Nuklearmedizin; 2011; 50(6):225-33. PubMed ID: 21989840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.
    Notni J; Steiger K; Hoffmann F; Reich D; Kapp TG; Rechenmacher F; Neubauer S; Kessler H; Wester HJ
    J Nucl Med; 2016 Mar; 57(3):460-6. PubMed ID: 26635338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.
    Beer AJ; Pelisek J; Heider P; Saraste A; Reeps C; Metz S; Seidl S; Kessler H; Wester HJ; Eckstein HH; Schwaiger M
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):178-87. PubMed ID: 24412187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
    Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
    J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.